# Columvi

NDC: 50242-127
Generic name: Glofitamab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20230615

FDA application: BLA761309

## Active ingredients

- GLOFITAMAB: 10 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-127"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-127
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3516e753-f064-4d30-9bd5-e3f2e143f75d
